Skip to content
★ Sign in to follow
AA

Abhi Acharya

Regen Biologics IncStereotaxis, Inc.
Total declarations
9
Companies
2
▲ Purchases (6 ops.)
€29k
▼ Sales (0 ops.)
—

Latest filing published 05 Mar 2008 for Stereotaxis, Inc., €3,918.

Insider track record

Disclosed buys
6
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
6
Positive at T+90
100%
Median T+90
+37.2%

Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 05 Mar 2008 · 6823 days ago · €3,918
    -11.8%
    Entry US$34.85 · Close at T+365 US$30.75

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Abhi Acharya: trading record in brief

Abhi Acharya is a declared insider at 2 companies; the most frequent names are Stereotaxis, Inc. and Regen Biologics Inc. We count 9 filings; the first trade dates from 30 November 2006 and the latest from 5 March 2008.

Purchases make up the whole of the open-market record (6 purchases, €29k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 3 option exercises. Since January 2008: 5 purchases and no sales on the market.

Half of the purchases are above €5,191 and half below. For 5 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +37.2%. These figures describe past trades and do not predict future prices.

Most recently, on 5 March 2008, the filings show an open-market purchase worth €3,918 in Stereotaxis, Inc. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Abhi Acharya

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total
  • ▲
    DirectorExecutivesStereotaxis, Inc.
    5,985 USD0SEC
    1,500 shares@ US$3.99Common StockSEC:0000950138-08-000177:0
    Canonical exit: 3 Jun 2008 (T+90)
  • ▲
    DirectorExecutivesStereotaxis, Inc.
    10,000 USD0SEC
    2,500 shares@ US$4.00Common StockSEC:0000950138-08-000177:1
    Canonical exit: 3 Jun 2008 (T+90)
  • ▲
    DirectorExecutivesStereotaxis, Inc.
    7,980 USD0SEC
    2,000 shares@ US$3.99Common StockSEC:0000950138-08-000177:2
    Canonical exit: 3 Jun 2008 (T+90)
  • ▲
    DirectorExecutivesStereotaxis, Inc.
    7,940 USD0SEC
    2,000 shares@ US$3.97Common StockSEC:0000950138-08-000177:3
    Canonical exit: 3 Jun 2008 (T+90)
  • ▲
    DirectorExecutivesStereotaxis, Inc.
    7,920 USD0SEC
    2,000 shares@ US$3.96Common StockSEC:0000950138-08-000177:4
    Canonical exit: 3 Jun 2008 (T+90)
  • ◇
    DirectorExecutivesStereotaxis, Inc.
    137,850 USD0SEC
    15,000 shares@ US$9.19Common StockSEC:0000950138-08-000008:0
  • ◇
    DirectorExecutivesStereotaxis, Inc.
    58,500 USD0SEC
    7,500 shares@ US$7.80Common StockSEC:0000950138-08-000008:1
  • ◇
    DirectorExecutivesStereotaxis, Inc.
    74,250 USD0SEC
    7,500 shares@ US$9.90Common StockSEC:0000950138-08-000008:2
  • ▲
    DirectorExecutivesRegen Biologics Inc
    3,700 USD0SEC
    10,000 shares@ US$0.37Common StockSEC:0001209191-06-062833:0
    Canonical exit: 28 Feb 2007 (T+90)

9 of 9 declarations